Enabling state of the art radiotherapy
Varian TrueBeam Auto Beam Hold
Varian’s Advanced IGRT & Motion package includes the Auto Beam Hold (ABH) feature. ABH is an imaging technique that monitors the patient during radiation treatments. This is achieved by detecting implanted fiducials in radiographic images acquired during treatment. The treatment beam is paused when ABH observes a discrepancy between the planned markers positions and the detected positions. Learn more
We believe that the combination of Gold Anchor and ABH creates unprecedented opportunities to provide safe and economical radiotherapy with high accuracy and precision.
Gold Anchor fiducial markers in prostate.
Gold Anchor fiducial markers in liver.
Gold Anchor fiducial markers in prostate, automatically detected by Varian TrueBeam®. Images courtesy of the Sahlgrenska University Hospital.
Note: Varian and Varian Medical Systems are registered trademarks, and TrueBeam® is a trademark of Varian Medical Systems, Inc.
Gold Anchor is great for proton therapy
- The thinner (0.28 mm diameter) Gold Anchor markers cause very little dose perturbation when they are implemented with a line shape.
- The high density material – gold – provides good visibility with kV imaging.
- The film measurements below show dose perturbation for a Gold Anchor implanted with a line-shape (assumed to form more of a zigzag shape) vs. regular gold markers.
Dose perturbation downstream of the markers with the markers oriented perpendicular to the beam axis near the end of the SOBP (Spread-Out Bragg Peak). The dose is normalized to an unperturbed region.
Source: Extract from “Investigation of dosimetric effects of radiopaque fiducial markers for use in proton beam therapy with film measurements and Monte Carlo simulations”
Gold Anchor can be tracked with the Cyberknife® system
- It is recommended to insert Gold Anchor as a ball shaped or tadpole shaped marker.
- However, 10 mm Gold Anchor markers can also be tracked when inserted as a line shape marker.
Example: Liver metastasis
Gold Anchor has so far been used for Cyberknife® treatments of lung, liver, pancreas, adrenal gland, and prostate.
- CyberKnife-based prostate cancer patient radioablation – Article (Gliwice, Poland)
- CyberKnife markers visible on CT and MRI – Poster at the SRS/SBRT Scientific Meeting 2014 (Austin CyberKnife)
- Using foldable Gold Anchor markers for fiducial tracking with the CyberKnife – Presentation at the 2011 CyberKnife® Robotic Radiosurgery Summit (Philadelphia CyberKnife)
Note: Cyberknife is one of the trademarks and/or registered trademarks of Accuracy Incorporated in the United States and other countries.
Gold Anchor enables a safer and easier radiation process
Man weighing 170 kilograms, 375 pound, with kidney cancer.
Pancreatic cancer. Circles indicates five days inter-fraction tumor movement.
Gold Anchor as a reference for an earlier field border in a new metastasis close to earlier treatment.
Gold Anchor as a reference for the caudal field border in a rectal cancer treatment.
- More accurate and precise than the frame technique – the marker indicates the true position.
- Reduced setup time in the treatment room compared to the xyz coordinate fram technique – better throughput.
- Intuitive and easy matching of orthogonal or CBCT images to DRR’s – increased safety and reduced risk of treatment errors.
Gold Anchor can be used be used with TomoTherapy® system
The best visibility is achieved by implanting a 0.4x20mm marker (GA200-20-B) with a ball shape.
These images show a Gold Anchor used for positioning of a liver SBRT patient. The CT study from the treatment planning step. The MVCT image was acquired with the TomoTherapy® Hi Art® treatment system immediately prior the treatment.
Note: TomoTherapy® and Hi Art® are registered or common law trademarks of TomoTherapy Incorporated in the United States and other countries.